{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:45:19Z","timestamp":1785761119005,"version":"3.56.0"},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":2216,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1111\/j.1749-6632.2000.tb05421.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T19:44:25Z","timestamp":1279655065000},"page":"560-567","source":"Crossref","is-referenced-by-count":41,"title":["Modulation of Anticancer Cytokines IL\u20102 and IL\u201012 by Melatonin and the Other Pineal Indoles 5\u2010Methoxytryptamine and 5\u2010Methoxytryptophol in the Treatment of Human Neoplasms"],"prefix":"10.1111","volume":"917","author":[{"given":"PAOLO","family":"LISSONI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01648882"},{"key":"e_1_2_6_3_2","first-page":"265","article-title":"Human dendritic cells: natural adjuvants in antitumor immunotherapy","volume":"4","author":"Nicola M.","year":"1998","journal-title":"Cytok. Cell. Molec. Ther."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.155.6.1823"},{"key":"e_1_2_6_5_2","first-page":"285","article-title":"Prognostic markers in interleukin\u20102 therapy","volume":"11","author":"Lissoni P.","year":"1996","journal-title":"Cancer Biother. Radiopharm."},{"key":"e_1_2_6_6_2","first-page":"1","article-title":"Neuroimmunomodulation","volume":"741","author":"Jankovic B.D.","year":"1994","journal-title":"From phenomenology to molecular evidence. Ann. N.Y. Acad. Sci."},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(93)90266-2"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1993.tb00478.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.159.2.574","article-title":"Melatonin enhances IL\u20102, IL\u20106 and IFN\u2010gamma production by human circulating CD4+ cells: a possible nuclear receptor\u2010mediated mechanisms involving T helper type 1 lymphocytes and monocytes","volume":"159","author":"Garcia\u2010Maurino S.","year":"1997","journal-title":"J. Immunol."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1995.tb00144.x"},{"key":"e_1_2_6_11_2","first-page":"S109","article-title":"The role of interleukin\u20102, interleukin\u201012, and dendritic cells in cancer therapy","volume":"3","author":"Lotze M.T.","year":"1997","journal-title":"Cancer J. Sci. Am."},{"key":"e_1_2_6_12_2","first-page":"196","article-title":"A randomised study with subcutaneous low\u2010dose interleukin\u20102 alone vs","volume":"69","author":"Lissoni P.","year":"1994","journal-title":"interleukin-2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma. Br. J. Cancer"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1993.tb00481.x"},{"key":"e_1_2_6_14_2","first-page":"27","article-title":"Immunomodulatory properties of a pineal indole hormone other than melatonin, the 5\u2010methoxytryptophol","volume":"10","author":"Lissoni P.","year":"1996","journal-title":"J. Biol. Regul. Homeostatic Agents"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701163360306"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.1.38"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.148.3666.102"},{"key":"e_1_2_6_18_2","first-page":"169","article-title":"Long\u2010term results of cancer immunotherapy with subcutaneous low\u2010dose interleukin\u20102 plus melatonin","author":"Lissoni P.","year":"1998","journal-title":"Int. J. Immunother."},{"key":"e_1_2_6_19_2","first-page":"194","article-title":"The pineal gland and cancer: facts, hypotheses and perspectives","volume":"5","author":"Bartsch C.","year":"1992","journal-title":"Cancer J."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0192-0561(89)90187-2"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1100177"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2000.tb05421.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2000.tb05421.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T12:51:52Z","timestamp":1695646312000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2000.tb05421.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1111\/j.1749-6632.2000.tb05421.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb05421.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}